Virology Testing Market to Experience Healthy Growth of
The main driving factors will be the rising incidence of viral infections, the appearance of novel pathogens, and an increase in the number of product...
Stay updated with breaking news from Testing Strips. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The main driving factors will be the rising incidence of viral infections, the appearance of novel pathogens, and an increase in the number of product...
The Global Continuous Glucose Monitoring Market's worth was USD 6.13 Billion in 2021 and will reach USD 16.33 Billion in 2030 with a 11.5% CAGR. One of the
NEW YORK, May 26, 2022 /PRNewswire/ -- The Insight Partners published latest research study on "Diabetes Care Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Glucose
>> reporter: while distribution of testing strips continues to grow in some major cities, not all states and cities are welcoming the idea. some opponents have criticized those strips for enabling drug users. >> i just don't think it is a good policy to make it easier for people addicted to drugs to use drugs. >> still, the white house has made its support clear. under the biden administration's new drug-control policy, the white house plans to expand access to harm-reduction services, like fentanyl testing strips by 25% in the next three years. >> the fact is that harm reduction save lives. >...
Like encouraging recreational drug users to engage with harm reduction and they cannot make it to the next step in their society if they die that night. that's why this is important. >> reporter: while distribution of testing strips continues to grow in some major cities, not all states and cities are welcoming the idea. some opponents have criticized those strips for enabling drug users. >> i just don't think it's a good policy to make it easier for people addicted to drugs to use drugs. >> reporter: still, the white house has made its support clear. under the biden administration's new drug ...